These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 7768606

  • 1. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi.
    Barthold SW, Fikrig E, Bockenstedt LK, Persing DH.
    Infect Immun; 1995 Jun; 63(6):2255-61. PubMed ID: 7768606
    [Abstract] [Full Text] [Related]

  • 2. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.
    Cassatt DR, Patel NK, Ulbrandt ND, Hanson MS.
    Infect Immun; 1998 Nov; 66(11):5379-87. PubMed ID: 9784547
    [Abstract] [Full Text] [Related]

  • 3. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES, Champion CI, Wu XY, Skare JT, Blanco DR, Miller JN, Lovett MA.
    Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
    [Abstract] [Full Text] [Related]

  • 4. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks.
    de Silva AM, Fish D, Burkot TR, Zhang Y, Fikrig E.
    Infect Immun; 1997 Aug; 65(8):3146-50. PubMed ID: 9234767
    [Abstract] [Full Text] [Related]

  • 5. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM, Gern L, Hauser P, Zhong W, Nielsen PJ, Kramer MD, Brenner C, Wallich R.
    Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
    [Abstract] [Full Text] [Related]

  • 6. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.
    Kurtti TJ, Munderloh UG, Hughes CA, Engstrom SM, Johnson RC.
    Infect Immun; 1996 Oct; 64(10):4148-53. PubMed ID: 8926082
    [Abstract] [Full Text] [Related]

  • 7. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.
    Vaccine; 1997 Oct; 15(6-7):739-46. PubMed ID: 9178476
    [Abstract] [Full Text] [Related]

  • 8. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
    Tsao J, Barbour AG, Luke CJ, Fikrig E, Fish D.
    Vector Borne Zoonotic Dis; 2001 Oct; 1(1):65-74. PubMed ID: 12653137
    [Abstract] [Full Text] [Related]

  • 9. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT, Burkot TR, Piesman J, Dolan MC, Capiau C, Hauser P, Dequesne G, Lobet Y.
    Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
    [Abstract] [Full Text] [Related]

  • 10. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W, Gern L, Kramer M, Wallich R, Simon MM.
    Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.
    Schwan TG, Piesman J.
    J Clin Microbiol; 2000 Jan; 38(1):382-8. PubMed ID: 10618120
    [Abstract] [Full Text] [Related]

  • 13. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ, Carner K, Liang X, Barbour AG.
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo.
    Hodzic E, Tunev S, Feng S, Freet KJ, Barthold SW.
    Infect Immun; 2005 Jun; 73(6):3313-21. PubMed ID: 15908357
    [Abstract] [Full Text] [Related]

  • 16. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
    Fikrig E, Telford SR, Barthold SW, Kantor FS, Spielman A, Flavell RA.
    Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5418-21. PubMed ID: 1608951
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.
    J Immunol; 2001 Jun 15; 166(12):7398-403. PubMed ID: 11390491
    [Abstract] [Full Text] [Related]

  • 18. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
    Fikrig E, Tao H, Barthold SW, Flavell RA.
    Infect Immun; 1995 May 15; 63(5):1658-62. PubMed ID: 7729870
    [Abstract] [Full Text] [Related]

  • 19. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
    Zhong W, Gern L, Stehle T, Museteanu C, Kramer M, Wallich R, Simon MM.
    Eur J Immunol; 1999 Mar 15; 29(3):946-57. PubMed ID: 10092099
    [Abstract] [Full Text] [Related]

  • 20. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
    Probert WS, LeFebvre RB.
    Infect Immun; 1994 May 15; 62(5):1920-6. PubMed ID: 8168958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.